"The effectiveness of long-term antibiotic therapy has not been confirmed (...), and may lead to significant side effects and result in antibiotic resistance selection in the entire Polish population. The medical literature precisely describes cases of complications after long-term antibiotic therapy used in Lyme disease," wrote Professor Milosz Parczewski, national consultant in infectious diseases, in an opinion sent to the Health Ministry. The document explains in detail why the ILADS method should not be used for patients struggling with Lyme disease.
The national consultant in infectious diseases recalls that the ILADS method has become a common basis in clinical practice in Poland for long-term (even more than a year or several years) use of many antibiotics, often in combinations (including B-lactams, rifampicin, metronidazole, macrolides and others). Such treatment, however,...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
